Biotechnology News

July 24, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18%

July 24, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: In continuation of their joint company announcement of July 23, 2014, BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), an innovative company specialized in the...

July 24, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it has extended a co-marketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services. The...

July 24, 2014

NEWTON, Mass.--(BUSINESS WIRE)--Unique combination of science, technology and healthcare found in Massachusetts enables the company to collaborate with innovative biotechs and healthcare organizations

July 24, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV), announces successful outcome of proceedings against Michael Gardner after almost 2 years of litigation. The International Center for Dispute Resolution International Arbitration Tribunal has...

July 24, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories announces its Investor Day on August 12, 2014 at 8:30 a.m. EDT in New York or via webcast at ir.criver.com

July 24, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that published results...

July 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND’s management team will host a conference call/audio webcast at 8:30 a.m. ET on Thursday, August 7, 2014 to discuss 2nd quarter 2014 financial results and recent business developments.

July 24, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent.

July 24, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the...

July 24, 2014

BLOOMINGTON, Ind.--(BUSINESS WIRE)--As announced at the 2014 Canadian Agency for Drugs and Technologies in Health (CADTH) symposium, the Canadian Network for Environmental Scanning in Health (CNESH) has selected Cook Medical’s Zilver® PTX® drug-...

July 24, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol)...

July 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 5, 2014, at 8:30 a.m. ET. During the call, management will review the company's second quarter 2014 financial results...

July 24, 2014

ATLANTA--(BUSINESS WIRE)--AMNIOX® Medical’s NEOX® and CLARIX® Product Lines Receive American Podiatric Medical Association (APMA) Seal of Approval

July 24, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Second Quarter 2014 Financial Results

July 24, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

July 24, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,845 million for the second quarter of 2014, an 18 percent increase from the same period in 2013. Second quarter total revenue increased 17 percent...

July 24, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that it will host a conference call and webcast to report its second quarter 2014 financial results on Thursday, July 31 at 8:30 a.m. ET. To participate in the...

July 24, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), today reported business highlights for the quarter ended June 30, 2014. The Company operates in two primary markets - wearable medical technology and point-of-care...

July 24, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter ended...

July 24, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2014 third quarter ended June 30, 2014, adjusted diluted earnings per share from continuing operations increased 29.5% percent to...

July 24, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results and...

July 24, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen will present aspects of its immune checkpoint related research at two upcoming scientific conferences, the Immunotherapies and Vaccines Summit and the Intl Conference on Immune Tolerance

July 24, 2014

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation announces that Gerald B. Blouch, president and CEO, will retire effective July 31, 2014. Robert K. Gudbranson, senior vice president and CFO, has been named interim CEO.

July 24, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the three and six months ended June 30, 2014. The Company reported net product sales of Soliris® (eculizumab) of $512.5 million...

July 24, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that the marketing authorization application for asfotase alfa has been validated and granted accelerated assessment by the European Medicines Agency.

July 24, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--GSK’s RTS,S is the world’s first malaria vaccine candidate to undergo regulatory review

July 24, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio, developer of therapeutics for severe infections, has raised up to $23 million in a Series E investment led by SR One with participation by Lundbeckfond Ventures and OrbiMed Israel

July 24, 2014

LUXEMBOURG--(BUSINESS WIRE)--DeepChek®-HIV is now available on BaseSpace Apps, Illumina’s applications store and informatics community where this dedicated HIV pipeline ease the analysis of next generation sequencing data.

July 24, 2014

LUXEMBOURG--(BUSINESS WIRE)--ABL and Roche Diagnostics International (EMEA and LATAM territories) renew collaboration for their products with integrated sequencing and analysis systems in HIV, viral hepatitis B and C.

July 24, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd., During July 10th - 12th, 2014, a group of 40 SHINIQUE VIP Customers, formed by managers of local or national beauty salon chains from all over China attended the second 'SHINIQUE Health...

July 24, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Milestone payments and sale of product rights bring profit in second quarter Second quarter 2014, April - June -- Net sales for April – June 2014 amounted to SEK 32 (12) million. -- Earnings after...

July 24, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) announced today at the 20th International AIDS Conference in Melbourne, Australia, a new agreement with the Medicines Patent Pool (MPP) to expand access to Gilead’s...

July 24, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it will acquire Cognigen Corporation of Buffalo, New York, a leading provider of clinical trial data analysis.

July 24, 2014

NEW YORK & OSAKA, Japan--(BUSINESS WIRE)--Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan

July 23, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President...

July 23, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--rEVO Biologics, Inc., a subsidiary of LFB Biotechnologies, today announced the enrollment of the first patient in its Phase 3 clinical trial of ATryn® [antithrombin (Recombinant)], for the treatment of...

July 23, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV)...

July 23, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2014. Total revenues for the second quarter of 2014 increased to $6.53 billion compared to $2.77...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina Reports Strong Results for Second Quarter of Fiscal Year 2014

July 23, 2014

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June...

July 23, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), an innovative company specialized in the development of drugs in orphan oncology diseases, and Topotarget A/S (NASDAQ OMX...

July 23, 2014

SHANGHAI & BETHLEHEM, Pa.--(BUSINESS WIRE)--Personalized Chemotherapy Tests Cleared for Use in China. Fosun Diagnostics receives CFDA Clearance for the Saladax MyCare™ Portfolio of Chemotherapy Exposure Optimization Tests.

July 23, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Kansas seeks to become model for nation -- Treating the whole person using advanced technological solution at 23 mental health centers.

July 23, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the Board of Directors has declared a quarterly dividend of $0.44 per share of the company’s common stock for the fourth quarter of 2014.

July 23, 2014

MARKHAM, Ontario--(BUSINESS WIRE)--Philips North America today launched the second annual Philips Innovation Fellows competition, and released the findings from its 2014 North America Innovation Report. According to the survey, three in five...

July 23, 2014

ANDOVER, Mass.--(BUSINESS WIRE)--Philips North America today announced the launch of the second annual Philips Innovation Fellows competition, in conjunction with the release of its 2014 North America Innovation Report. According to the report,...